Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment. [electronic resource]
Producer: 20210326ISSN:- 2073-4425
- Adolescent
- Antimetabolites, Antineoplastic -- adverse effects
- Biomarkers, Tumor -- genetics
- Child
- Child, Preschool
- Drug-Related Side Effects and Adverse Reactions -- diagnosis
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Genotype
- Humans
- Infant
- Male
- Methotrexate -- adverse effects
- Pharmacogenetics
- Polymorphism, Single Nucleotide
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.